Skip to content
Immutep refocuses efti development on head and neck cancer and soft tissue sarcoma episode artwork

Sep 16, 2026

Immutep refocuses efti development on head and neck cancer and soft tissue sarcoma

from Latest Interviews - Finance News Network Hosted by Finance News Network

17 Sept 2026 - CEO Marc Voigt outlines Immutep’s focused clinical strategy, ongoing TACTI-004 analysis and plans to return efti to the clinic in 2027.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Immutep refocuses efti development on head and neck cancer and soft tissue sarcoma

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

When was this Latest Interviews - Finance News Network episode published?

This episode was published on September 16, 2026.

Can I download this Latest Interviews - Finance News Network episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.